Skip to main content
Go to the U of M home page
  • One Stop
  • MyU

Federal Executive Orders & Other Directives

University leaders are monitoring federal changes and executive orders that could affect research projects and programs (updated 6/13/25): z.umn.edu/fed-impacts
 

Research & Innovation Office

Office of Biotechnology Activities Oversight

Contact Us
Menu
  • About Us
    • Office of Biotechnology Activities Oversight
    • Contact Us
  • eProtocol
  • Research Oversight Areas
    • Institutional Biosafety Committee (IBC)
    • Stem Cell Research Oversight (SCRO)
    • Clinical Trials and the IBC
    • Fetal Tissue Research (FTR)
    • Dual Use Research for Concern – Pathogens with Enhanced Pandemic Potential (DURC-PEPP)
      • DURC-PEPP Overview
      • DURC-PEPP Policy
      • Implementation Guidance
  • Institutional Biosafety Committee
    • IBC Oversight
    • IBC Application Process & General Info
      • General Recommendations
      • Minimal Risk Application Guidelines
      • New IBC Protocols & Renewals
      • IBC Applications for Teaching Laboratories
      • Amendments to IBC Applications
      • Annual Continuing Reviews
      • Post Submission Process
      • Post Review Process
      • Post Approval Process
      • Risk Assessment & Biosafety Containment Levels
      • IBC Guidance for Core Facilities
      • Shipment of r/sNA Contained in Organisms or Viral Genomes
      • Poliovirus Containment
    • IBC Meeting & Submission Deadlines
    • Application Sections
      • Personnel Information
      • Activities Include
      • Funding
      • Study Objectives
      • r/sNA
      • Biological Toxins
      • Infectious Agents
      • Human Clinical Trials
      • Genetic Modification of Animals
      • Safety
      • Attachments
      • Assurance
      • Check for Completeness
      • Submit Form
    • IBC Committee
    • IBC Policies
  • Incident Reporting
  • Training & Education
    • IBC Training & Educational Resources
    • Stem Cell Research Oversight (SCRO)
    • Human Gene Transfer (HGT)
    • Dual Use Research for Concern (DURC)
    • Fetal Tissue Research (FTR)

Promoting Safety & Ethics in Biological Research

Providing administrative support to the University community and the committees responsible for oversight in areas of biosafety and biosecurity. Assessing the scientific, ethical, and social implications of certain biotechnologies.

Research Oversight Areas

  • Institutional Biosafety Committee (IBC)
  • Stem Cell Research Oversight (SCRO)
  • Clinical Trials
  • Dual Use Research for Concern - Pathogens with Enhanced Pandemic Potential
  • Fetal Tissue Research (FTR)

Office of Biotechnology Activities Oversight

Suite 280 McNamara Alumni Center
200 Oak Street S.E.
Minneapolis, MN 55455
United States

[email protected] (612) 626-2161
  • Contact Us
University of Minnesota wordmark

Announcements for the UMN Research Community

Sign up for the UMN Research newsletter

SYSTEM CAMPUSES

System Website

Crookston

Duluth

Morris

Rochester

Twin Cities

For Students, Faculty, and Staff

  • One Stop
  • MyU
© 2025 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement | Report Web Disability-Related Issues
  • About Us
    • Office of Biotechnology Activities Oversight
    • Contact Us
  • eProtocol
  • Research Oversight Areas
    • Institutional Biosafety Committee (IBC)
    • Stem Cell Research Oversight (SCRO)
    • Clinical Trials and the IBC
    • Fetal Tissue Research (FTR)
    • Dual Use Research for Concern – Pathogens with Enhanced Pandemic Potential (DURC-PEPP)
      • DURC-PEPP Overview
      • DURC-PEPP Policy
      • Implementation Guidance
  • Institutional Biosafety Committee
    • IBC Oversight
    • IBC Application Process & General Info
      • General Recommendations
      • Minimal Risk Application Guidelines
      • New IBC Protocols & Renewals
      • IBC Applications for Teaching Laboratories
      • Amendments to IBC Applications
      • Annual Continuing Reviews
      • Post Submission Process
      • Post Review Process
      • Post Approval Process
      • Risk Assessment & Biosafety Containment Levels
      • IBC Guidance for Core Facilities
      • Shipment of r/sNA Contained in Organisms or Viral Genomes
      • Poliovirus Containment
    • IBC Meeting & Submission Deadlines
    • Application Sections
      • Personnel Information
      • Activities Include
      • Funding
      • Study Objectives
      • r/sNA
      • Biological Toxins
      • Infectious Agents
      • Human Clinical Trials
      • Genetic Modification of Animals
      • Safety
      • Attachments
      • Assurance
      • Check for Completeness
      • Submit Form
    • IBC Committee
    • IBC Policies
  • Incident Reporting
  • Training & Education
    • IBC Training & Educational Resources
    • Stem Cell Research Oversight (SCRO)
    • Human Gene Transfer (HGT)
    • Dual Use Research for Concern (DURC)
    • Fetal Tissue Research (FTR)